COCP · NASDAQ
Cocrystal Pharma (COCP) Stock Price & Fundamentals
Cocrystal Pharma (COCP) closed at $636.94 on Oct 9, 2026, down 0.27% from the previous close of $638.68.
Share price, past year
1Y +67.85%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $636.94 |
| Sep 30, 2026 | $623.53 |
| Aug 31, 2026 | $593.99 |
| Jul 31, 2026 | $578.62 |
| Jun 30, 2026 | $580.02 |
| May 29, 2026 | $536.67 |
| Apr 30, 2026 | $496.23 |
| Mar 31, 2026 | $508.70 |
| Feb 27, 2026 | $482.13 |
| Jan 30, 2026 | $456.99 |
| Dec 31, 2025 | $420.68 |
| Nov 28, 2025 | $412.02 |
| Oct 31, 2025 | $396.39 |
Key statistics
- Market cap
- $8.78B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.75
- Revenue (TTM)
- —
- Net income (TTM)
- −$9.94M
- Shares outstanding
- 13.8M
- Dividend yield
- —
- 52-week range
- $377.64 – $638.68
Cocrystal Pharma's market cap is $8.78B, based on a share price of $636.94 and 13.8M shares outstanding as of Jun 30, 2026.
Financials
Cocrystal Pharma reported revenue of $2.01M for fiscal 2020, down 69.32% from fiscal 2019.
Cocrystal Pharma reported a net loss of $8.83M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2020ended Dec 31, 2020 | $2.01M | −69.3% | −$9.65M | −479.1% | −$0.17 | −$10.07M |
| FY2019ended Dec 31, 2019 | $6.56M | −48.4% | −$48.17M | −733.8% | −$1.51 | −$1.71M |
| FY2011ended Dec 31, 2011 | $12.71M | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $105.00K | −$3.16M | −$0.23 |
| Q1 FY2026ended Mar 31, 2026 | $225.00K | −$2.30M | −$0.17 |
| Q4 FY2020ended Dec 31, 2020 | $510.00K | — | — |
| Q3 FY2020ended Sep 30, 2020 | $489.00K | — | — |
| Q2 FY2020ended Jun 30, 2020 | $554.00K | — | — |
| Q1 FY2020ended Mar 31, 2020 | $461.00K | — | — |
| Q4 FY2019ended Dec 31, 2019 | $402.00K | — | — |
| Q3 FY2019ended Sep 30, 2019 | $492.00K | — | — |
Company profile
- Name
- Cocrystal Pharma, Inc.
- Ticker
- COCP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 19805 N. Creek Parkway, Bothell, WA 98011
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001412486
Recent SEC filings
- Sep 9, 2026
- Aug 18, 2026
- Aug 17, 2026
- Aug 13, 2026
- Aug 3, 2026
- Jul 17, 2026
- Jun 9, 2026
- Jun 3, 2026
Frequently asked questions
What is Cocrystal Pharma's stock price?
Cocrystal Pharma (COCP) closed at $636.94 on Oct 9, 2026, down 0.27% from the previous close of $638.68.
What is Cocrystal Pharma's market cap?
Cocrystal Pharma's market cap is $8.78B, based on a share price of $636.94 and 13.8M shares outstanding as of Jun 30, 2026.
How much revenue does Cocrystal Pharma make?
Cocrystal Pharma reported revenue of $2.01M for fiscal 2020, down 69.32% from fiscal 2019.
Does Cocrystal Pharma pay a dividend?
Cocrystal Pharma's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cocrystal Pharma, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures